Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.450
-0.100 (-3.92%)
Nov 4, 2024, 4:00 PM EST - Market closed

Moleculin Biotech Stock Forecast

MBRX's stock price has decreased by -68.04% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Moleculin Biotech stock have an average target of 35, with a low estimate of 20 and a high estimate of 45. The average target predicts an increase of 1,328.57% from the current stock price of 2.45.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $20 $35 $40 $45
Change +716.33% +1328.6% +1532.7% +1736.7%
* Price targets were last updated on Apr 12, 2024.

Analyst Ratings

The average analyst rating for MBRX stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 333333
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 333333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Roth MKM
Roth MKM
Strong Buy
Maintains
$40
Strong Buy Maintains $40 +1,532.65% Apr 12, 2024
Maxim Group
Maxim Group
Strong Buy
Maintains
$45$20
Strong Buy Maintains $45$20 +716.33% Mar 26, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$45
Strong Buy Initiates $45 +1,736.73% Dec 14, 2023
Roth MKM
Roth MKM
Strong Buy
Maintains
$240
Strong Buy Maintains $240 +9,695.92% Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Reiterates
$75
Buy Reiterates $75 +2,961.22% Mar 24, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-7.63
from -15.07
EPS Next Year
-5.99
from -7.63
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
--------
Revenue Growth
--------
EPS
-29.18-26.44-8.87-15.22-15.07-7.63-5.99-5.89
EPS Growth
--------
Forward PE
--------
No. Analysts -----555
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202420252026
High -7.85 -6.16 -6.06
Avg -7.63 -5.99 -5.89
Low -7.33 -5.75 -5.65

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.